NGS and precision oncology in South Korea: insights from Prof Kim Jee-Hyun
In this article, Prof Jee Hyun Kim explains her clinical experiences of NGS, and how she sees it evolving within South Korea’s innovative healthcare ecosystem.
Read MoreYou are about to leave the Clinical Value website now.
Cancel
Continue
NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff
You May Also Like
Next-generation sequencing (NGS) drives precision oncology in Singapore
In this article, Dr David Tan discusses the potential of NGS in Singapore, where the adoption of this technology is only just beginning to take root.
Read MoreNGS and precision oncology in Hong Kong: insights from Dr Lam Tai-Chung
In this article, Dr Lam Tai-Chung shares how his institution has had first-hand experience of landmark cases and outstanding treatment responses from using NGS in seemingly terminal patients.
Read More